- A tiny GLP-1 implant is the latest bet to help patients maintain their weight loss CNBC
- Novo Nordisk signs pact with Vivani for long-lasting semaglutide implant Yahoo Finance
- Biotech CEO on new Novo Nordisk partnership: “This could be big” medwatch.com
- Ozempic & Wegovy Maker To Evaluate Long-Acting GLP-1 Implant That Could Last Up To A Year Health and Me
- Vivani develops semaglutide implant to improve long-term weight loss adherence for GLP-1 users Pluang
Add Comment